Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 8,360.00
+290.00 (3.59%)
Sep 1, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 746.5 billion as of September 1, 2026. Its market cap has decreased by -5.32% in one year.
Market Cap
746.50B
Enterprise Value
1.81T
Revenue
1.31T
Ranking
n/a
PE Ratio
59.41
Stock Price
8,360.00
ChartMarket Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 746.50B, an increase of 123.41%. That is a compound annual growth rate of 4.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 746.50B | -33.31% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 1.43T |
| Pharmicell | 673.25B |
| Onconic Therapeutics | 670.67B |
| Komipharm International | 669.89B |
| Hyundai Bioscience | 631.13B |
| GI Innovation | 521.93B |
| AbClon | 519.75B |
| Medy-Tox | 463.40B |